Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-102682
Filing Date
2025-10-27
Accepted
2025-10-27 17:27:18
Documents
1
Period of Report
2025-10-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4333
  Complete submission text file 0001213900-25-102682.txt   5847
Mailing Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
STEINMAN LAWRENCE (Reporting) CIK: 0001132679 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-40804 | Film No.: 251420733

Mailing Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139 (702) 514-4174
Pasithea Therapeutics Corp. (Issuer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)